Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bolla

Showing results (191-200 of 237) with videos related to

Pageof 24
Sort By:
Progress in Clinical and Biological Research|January 1, 1987
Prostate cancer: results of radiotherapy in French cancer institutesY M Allain, M Bolla, D Brune, et al.
Bulletin Du Cancer|September 8, 1999
[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer : multicentric retrospective study I. DNA synthesis enzyme activities]F Spyratos, S Romain, B Rostaing-Puissant, et al.
Bulletin Du Cancer|September 1, 1996
[Prognostic value of quantitative DNA analysis, expressed in integrated optical density, in a series of 415 T1-T2, N0N1, M0 UICC breast cancers]M Bolla, D Seigneurin, P Winckel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1996
Feasibility of retroperitoneal pelvic lymph node exploration in cervical carcinoma. Assessment of morbidity in 33 cases treated by combined radio-surgery or definitive radiotherapyM Bolla, J Salvat, R Sarrazin, et al.
Bulletin Du Cancer|December 1, 1994
[Modulation of indications of adjuvant hormone therapy with tamoxifen in T1T2/N0N1 breast cancers. Preliminary results of a multicenter study with 695 cases]M Bolla, M Mousseau, P Winckel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1995
EORTC guidelines for writing protocols for clinical trials of radiotherapyM Bolla, H Bartelink, G Garavaglia, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1992
Prostate cancer treated by radiotherapy: a multivariate studyE Albuisson, Y M Allain, R Rozan, et al.
Breast Cancer Research and Treatment|January 1, 1994
Lack of prognostic value of epidermal growth factor receptor in a series of 229 T1/T2, N0/N1 breast cancers, with well defined prognostic parametersM Bolla, M Chedin, M Colonna, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]D Poncet, V Arnoux, J Descotes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1989
Sequential combination of 5-fluorouracil, cis-platinum and irradiation in unresectable non-small cell lung cancerH Nagy-Mignotte, M Bolla, B Wuyam, et al.
Pageof 24

Showing results (191-200 of 237) with videos related to

Sort By:
Pageof 24
Progress in Clinical and Biological Research|January 1, 1987
Prostate cancer: results of radiotherapy in French cancer institutesY M Allain, M Bolla, D Brune, et al.
Bulletin Du Cancer|September 8, 1999
[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer : multicentric retrospective study I. DNA synthesis enzyme activities]F Spyratos, S Romain, B Rostaing-Puissant, et al.
Bulletin Du Cancer|September 1, 1996
[Prognostic value of quantitative DNA analysis, expressed in integrated optical density, in a series of 415 T1-T2, N0N1, M0 UICC breast cancers]M Bolla, D Seigneurin, P Winckel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1996
Feasibility of retroperitoneal pelvic lymph node exploration in cervical carcinoma. Assessment of morbidity in 33 cases treated by combined radio-surgery or definitive radiotherapyM Bolla, J Salvat, R Sarrazin, et al.
Bulletin Du Cancer|December 1, 1994
[Modulation of indications of adjuvant hormone therapy with tamoxifen in T1T2/N0N1 breast cancers. Preliminary results of a multicenter study with 695 cases]M Bolla, M Mousseau, P Winckel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1995
EORTC guidelines for writing protocols for clinical trials of radiotherapyM Bolla, H Bartelink, G Garavaglia, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1992
Prostate cancer treated by radiotherapy: a multivariate studyE Albuisson, Y M Allain, R Rozan, et al.
Breast Cancer Research and Treatment|January 1, 1994
Lack of prognostic value of epidermal growth factor receptor in a series of 229 T1/T2, N0/N1 breast cancers, with well defined prognostic parametersM Bolla, M Chedin, M Colonna, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]D Poncet, V Arnoux, J Descotes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1989
Sequential combination of 5-fluorouracil, cis-platinum and irradiation in unresectable non-small cell lung cancerH Nagy-Mignotte, M Bolla, B Wuyam, et al.
Pageof 24